ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Gain Therapeutics Inc

Gain Therapeutics Inc (GANX)

2,21
0,05
(2,31%)
Fermé 05 Février 10:00PM
2,21
0,00
( 0,00% )
Avant marché: 10:00AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
2,21
Prix Achat
1,97
Prix Vente
2,30
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,89 Plage de 52 semaines 5,33
Cap du marché
Clôture Veille
2,21
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
228 609
Actions en circulation
26 525 068
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,65
Bénéfice par action (BPA)
-0,83
Chiffre d'affairess
55k
Bénéfice net
-22,11M

À propos de Gain Therapeutics Inc

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applicatio... Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Gain Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker GANX. Le dernier cours de clôture d'Gain Therapeutics était de US$2,21. Au cours de la dernière année, les actions de Gain Therapeutics ont été négociées dans une fourchette de prix de US$ 0,89 à US$ 5,33.

Gain Therapeutics compte actuellement 26 525 068 actions en circulation. La capitalisation boursière d'Gain Therapeutics est de US$58,62 million. Gain Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.65.

GANX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.136.252.082.291.9751813882.15915035CS
4-0.1332-5.684533970642.34322.51.961650482.21061339CS
120.094.245283018872.122.64961.52286091.94083833CS
261.25723131.9552462820.952773.190.893122531.7907267CS
52-1.77-44.4723618093.985.330.892682932.08652284CS
156-2.46-52.67665952894.676.70.891357112.65200922CS
260-9.01-80.30303030311.2217.930.891258373.79909613CS

GANX - Frequently Asked Questions (FAQ)

What is the current Gain Therapeutics share price?
The current share price of Gain Therapeutics is US$ 2,21
How many Gain Therapeutics shares are in issue?
Gain Therapeutics has 26 525 068 shares in issue
What is the market cap of Gain Therapeutics?
The market capitalisation of Gain Therapeutics is USD 58,62M
What is the 1 year trading range for Gain Therapeutics share price?
Gain Therapeutics has traded in the range of US$ 0,89 to US$ 5,33 during the past year
What is the PE ratio of Gain Therapeutics?
The price to earnings ratio of Gain Therapeutics is -2,65
What is the cash to sales ratio of Gain Therapeutics?
The cash to sales ratio of Gain Therapeutics is 1,05k
What is the reporting currency for Gain Therapeutics?
Gain Therapeutics reports financial results in USD
What is the latest annual turnover for Gain Therapeutics?
The latest annual turnover of Gain Therapeutics is USD 55k
What is the latest annual profit for Gain Therapeutics?
The latest annual profit of Gain Therapeutics is USD -22,11M
What is the registered address of Gain Therapeutics?
The registered address for Gain Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Gain Therapeutics website address?
The website address for Gain Therapeutics is www.gaintherapeutics.com
Which industry sector does Gain Therapeutics operate in?
Gain Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OPOFOld Point Financial Corporation
US$ 39,51
(58,99%)
4
TWINTwin Disc Inc
US$ 17,88
(58,93%)
27
IBACIB Acquisition Corporation
US$ 16,24
(58,90%)
2
ADSEADD TEC Energy PLC
US$ 23,39
(56,66%)
12
AFRIForafric Global PLC
US$ 14,99
(56,15%)
19
SBFGSB Finanical Group Inc
US$ 12,22
(-46,85%)
10
THRYThryv Holdings Inc
US$ 10,01
(-46,01%)
4
IROQIF Bancorp Inc
US$ 15,00
(-38,17%)
200
AURAAura Biosciences Inc
US$ 5,01
(-37,38%)
1
WMPNWilliam Penn Bancorporation
US$ 8,00
(-35,22%)
201
CYNCYNGN Inc
US$ 0,0793
(11,69%)
12,52M
SXTP60 Degrees Pharmaceuticals Inc
US$ 0,8758
(46,70%)
9,63M
UPCUniverse Pharmaceuticals Inc
US$ 0,325
(20,41%)
5,51M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,50
(50,00%)
5,01M
RIMEAlgorhythm Holdings Inc
US$ 0,026
(6,56%)
4,26M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock